XML 26 R15.htm IDEA: XBRL DOCUMENT v3.25.3
Note 8 - Stock-based Compensation
 9 Months Ended
Oct. 31, 2025
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 8 - Stock-based compensation 

 

The Company has prior incentive plans under which previously granted awards remain outstanding, but under which no new awards may be granted, including the Company's 2021 Omnibus Stock Incentive Plan, which expired in May 2024. At  October 31, 2025, the Company had reserved a total of 197,151 shares for grants and issuances under these incentive plans, including issuances pursuant to unvested or unexercised prior awards.

 

The Company's 2024 Omnibus Stock Incentive Plan, dated May 28, 2024, was approved by the Company's stockholders in July 2024 ("2024 Plan"). The 2024 Plan will expire in July 2027. The 2024 Plan authorizes awards to officers, employees, consultants, and independent directors. The 2024 Plan provides for the grant of deferred shares, non-qualified stock options, incentive stock options, restricted shares, restricted stock units, and performance-based restricted stock units intended to qualify under section 422 of the Internal Revenue Code.

 

Grants were made in connection with the 2024 Plan and the prior incentive plans to employees, officers, and independent directors, as further described below.   

 

Stock-based compensation expense

 

The Company has granted stock-based compensation awards to eligible employees, officers and independent directors. The Company recognized the following stock-based compensation expense for the periods presented:

 

  

Three Months Ended October 31,

  

Nine Months Ended October 31,

 
  

2025

  

2024

  

2025

  

2024

 

Restricted stock-based compensation expense

 $320  $232  $2,012  $629 

 

Restricted stock

 

The following table summarizes the Company's restricted stock activity for the nine months ended  October 31, 2025:

 

  

Restricted Shares

  

Weighted Average Price (Per share)

  

Aggregate Intrinsic Value

 

Outstanding at January 31, 2025

  230  $9.05  $2,080 

Granted

  90   21.61     

Vested and issued

  (111)  10.99     

Forfeited or retired for taxes

  (22)  17.37     

Outstanding at October 31, 2025

  187  $17.48  $3,245 

 

As of October 31, 2025, there was $1.8 million of unrecognized compensation expense related to unvested restricted stock granted under the plans. These costs are expected to be recognized over a weighted average period of 2.2 years.